Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medicines Co (NASDAQ:MDCO)

33.42
Delayed Data
As of Dec 02
 -0.07 / -0.21%
Today’s Change
27.50
Today|||52-Week Range
42.15
-10.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$2.4B

Company Description

The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on leading acute and intensive care hospitals worldwide. The company markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.

Contact Information

The Medicines Co.
8 Sylvan Way
Parsippany New Jersey 07054-3801
P:(973) 290-6000
Investor Relations:
(973) 290-6122

Employees

Shareholders

Mutual fund holders69.77%
Other institutional55.08%
Individual stakeholders13.85%

Top Executives

Clive A. MeanwellChief Executive Officer & Director
Tony KingsleyPresident & Chief Operating Officer
Bill O'ConnorSVP, Chief Financial & Accounting Officer
David KallendVice President & Global Medical Director
John W. VilligerExecutive Vice President